Fitzgerald Meghan: insider trades.
Fitzgerald Meghan reported 8 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.4M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Fitzgerald Meghan
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Roivant Sciences Ltd. (ROIV) | Director | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Roivant Sciences Ltd. | A | 5,054 | $0 | 41,162 | Form 4 |
| 2026-09-15 | Roivant Sciences Ltd. | S | 400 | $40.45 | 36,108 | Form 4 |
| 2026-09-15 | Roivant Sciences Ltd. | S | 4,712 | $39.68 | 36,508 | Form 4 |
| 2026-09-10 | Roivant Sciences Ltd. | F | 1,743 | $40.94 | 41,220 | Form 4 |
| 2026-09-08 | Roivant Sciences Ltd. | S | 20,000 | $39.9 | 42,963 | Form 4 |
| 2026-09-08 | Roivant Sciences Ltd. | M | 20,000 | $8.8 | 62,963 | Form 4 |
| 2026-06-30 | Roivant Sciences Ltd. | M | 10,000 | $8.8 | 52,963 | Form 4 |
| 2026-06-30 | Roivant Sciences Ltd. | S | 10,000 | $34.9 | 42,963 | Form 4 |
Questions
What stock did Fitzgerald Meghan buy or sell?
Fitzgerald Meghan reported 8 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.4M), across 1 company.
Is Fitzgerald Meghan the same person as other filers with this name?
This page covers SEC CIK 1349297 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/fitzgerald-meghan-1349297.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.